VivoSim Labs, Inc.

VIVS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 16, 2026 8-K
8-K Oct 6, 2026 8-K
4 Sep 1, 2026 4
ARS Aug 21, 2026 ARS
8-K Aug 21, 2026 8-K
DEF 14A Aug 21, 2026 DEF 14A
SCHEDULE 13G/A Aug 17, 2026
PRER14A Aug 13, 2026 PRER14A
10-Q Aug 12, 2026 10-Q
EFFECT Aug 10, 2026
PRE 14A Aug 10, 2026 PRE 14A
8-K Aug 6, 2026 8-K
S-1 Jul 31, 2026 S-1
8-K Jul 30, 2026 8-K
8-K Jul 24, 2026 CURRENT REPORT
8-K Jul 17, 2026 8-K
10-K Jul 14, 2026 10-K
NT 10-K Jun 29, 2026 NT 10-K
SCHEDULE 13G Apr 6, 2026
8-K Apr 3, 2026 8-K
424B4 Apr 2, 2026 PROSPECTUS
EFFECT Mar 31, 2026
CORRESP Mar 31, 2026
CORRESP Mar 31, 2026
S-1/A Mar 31, 2026 AMENDMENT NO. 1 TO FORM S-1
← Newer Page 1 of 33 · 819 filings Older →